Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IGF2BP2 Regulates MALAT1 by Serving as an N6-Methyladenosine Reader to Promote NSCLC Proliferation
Le Han, Guangyan Lei, Zhenghong Chen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 39
IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
Meiqi Duan, Haiyang Liu, Shasha Xu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 890-920
Open Access | Times Cited: 25
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 11
Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks
Э. А. Брага, М. В. Фридман, A. M. Burdennyy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13617-13617
Open Access | Times Cited: 22
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 20
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification
Yimin Feng, Fengjuan Wu, Yuanning Wu, et al.
Translational Oncology (2023) Vol. 32, pp. 101661-101661
Open Access | Times Cited: 19
IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway
Dong Liu, A-Dong Xia, Le-Ping Wu, et al.
Cellular Signalling (2022) Vol. 94, pp. 110313-110313
Closed Access | Times Cited: 27
Novel Insights into The Roles of N6-methyladenosine (m6A) Modification and Autophagy in Human Diseases
Jiaxin Liang, Jingwen Sun, Wei Zhang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 705-720
Open Access | Times Cited: 15
Targeting insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) for the treatment of cancer
Yuanqian Cai, Yingzhe Wang, Bingjie Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116241-116241
Closed Access | Times Cited: 5
IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma
Ning Li, Limei Deng, Yuming Zhang, et al.
Ibrain (2024) Vol. 10, Iss. 1, pp. 19-33
Open Access | Times Cited: 5
Crosstalk between m6A modification and autophagy in cancer
Tao Chen, Liying Zheng, Peiyue Luo, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response
Francisco J. Enguita, Ana Lúcia Leitão, J. Tyson McDonald, et al.
Theranostics (2022) Vol. 12, Iss. 8, pp. 3946-3962
Open Access | Times Cited: 22
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization
Shengjia Shi, Donghui Han, Jingliang Zhang, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 3
Open Access | Times Cited: 11
IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6A‐dependent manner
Yaqian Shi, Xueyou Xiong, Yu Sun, et al.
The FASEB Journal (2023) Vol. 37, Iss. 10
Closed Access | Times Cited: 11
Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target
Shilpee Chanda, Konstantin Lepikhov, Charlotte Dahlem, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 1, pp. 41-41
Open Access | Times Cited: 4
Multifaceted roles of insulin‑like growth factor 2 mRNA binding protein 2 in human cancer (Review)
Jianan Shen, Youxiang Ding
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Closed Access
Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis
Hongkun Cai, Jingyuan Zhao, Qiyue Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167183-167183
Closed Access | Times Cited: 3
In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases
Naoko Suga, Yuka Ikeda, Sayuri Yoshikawa, et al.
Neurology International (2023) Vol. 15, Iss. 3, pp. 967-979
Open Access | Times Cited: 8
Systematic analysis of IGF2BP family members in non-small-cell lung cancer
Liping Gong, Qin Liu, Ming Jia, et al.
Human Genomics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
N6-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing
Anqi Wang, Yuanyuan Zeng, Weijie Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
A review of current developments in RNA modifications in lung cancer
Shujun Zhang, Yafeng Liu, Kaijie Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance
Feiyang Wang, Qianjin Liao, Zihao Qin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 2
The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer
Yiyang Sun, Ping He, Li Li, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 6
The therapeutic potential of RNA m(6)A in lung cancer
Jian Yu, Sun Wei, Xiangxuan Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Current and potential roles of RNA modification-mediated autophagy dysregulation in cancer
Hua Huang, Ruining Pan, Sijia Wang, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 736, pp. 109542-109542
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top